The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
|
---|---|
Published in |
Frontiers in oncology, September 2021
|
DOI | 10.3389/fonc.2021.710596 |
Pubmed ID | |
Authors |
Fara Brasó-Maristany, Miriam Sansó, Nuria Chic, Débora Martínez, Blanca González-Farré, Esther Sanfeliu, Lucio Ghiglione, Esther Carcelero, Javier Garcia-Corbacho, Marcelo Sánchez, Dolors Soy, Pedro Jares, Vicente Peg, Cristina Saura, Montserrat Muñoz, Aleix Prat, Ana Vivancos |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 13% |
Germany | 1 | 7% |
Unknown | 12 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 60% |
Scientists | 4 | 27% |
Practitioners (doctors, other healthcare professionals) | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 14% |
Student > Bachelor | 3 | 10% |
Other | 2 | 7% |
Professor > Associate Professor | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Other | 4 | 14% |
Unknown | 12 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 21% |
Biochemistry, Genetics and Molecular Biology | 5 | 17% |
Unspecified | 1 | 3% |
Neuroscience | 1 | 3% |
Immunology and Microbiology | 1 | 3% |
Other | 0 | 0% |
Unknown | 15 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2022.
All research outputs
#2,468,335
of 26,163,973 outputs
Outputs from Frontiers in oncology
#566
of 22,913 outputs
Outputs of similar age
#54,403
of 439,828 outputs
Outputs of similar age from Frontiers in oncology
#20
of 1,414 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,828 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 1,414 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.